Hua Medicine (Shanghai) (HUMDF) Stock Price, News & Analysis

Company Overview

Hua Medicine (Shanghai) Limited is a China-based biopharmaceutical company focused on developing and commercializing innovative treatments for metabolic diseases, particularly type 2 diabetes. The company’s research platform centers on therapies designed to address the underlying biological mechanisms associated with impaired glucose regulation.

Its lead product is dorzagliatin, an oral glucokinase activator developed to improve glucose sensing and insulin regulation. Dorzagliatin was approved in China in 2022 and is marketed under the brand name HuaTangNing for the treatment of adults with type 2 diabetes. It is the company’s principal commercial product and the first glucokinase activator approved for this indication in China.

Hua Medicine was established in 2010 and is headquartered in Shanghai. Its activities primarily serve the Chinese pharmaceutical market, while the company has also pursued international development and commercialization opportunities for its metabolic disease therapies. Dr. Chen Li is the company’s founder and chief executive officer.

Key Stats

• Today's Range: C$0.30 to C$0.30
• 50-Day Range: C$0.29 to C$0.34
• 52-Week Range: C$0.29 to C$0.50
• Volume: N/A
• Average Volume: 7,682 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:HUMDF
• CIK: N/A
• Web: www.huamedicine.com
• Phone: +862158865599
• Fax: N/A
• Employees: 328
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A